Back to Podcast
Next Day Prep #241 Bullish

Next Day Prep #241: Regime Thresholds & PPI Trigger – Monday 4/13/2026

April 13, 2026 5:05
Episode Summary
The regime stays Cautious despite strong breadth and sentiment—because only structural evidence, not noise, moves the needle. With PPI looming, we break down the exact thresholds that could flip the regime—and why RVMD’s setup was textbook.
Key Takeaways
  • Revolution Medicines +41.4% on practice-changing Phase 3 data, validating biotech breakout
  • Technology sector ATR hit all-time high at 1.51%, leading broadening breadth
  • 41% of stocks above 40 SMA — regime holds at Cautious but trend improving
  • PPI and JPM/WFC/Earnings headline tomorrow — key regime test on horizon
  • Top setups: RVMD breakout, ALM momentum, AMG zone bounce — focus on tight VCP entries
0:00 / 5:05

Situation Awareness: Cautious. The market opened with selling pressure tied to failed U.S.-Iran ceasefire talks and a U.S. naval blockade of Iranian ports, but quickly reversed course as tech leadership, strong software earnings, and optimism around diplomatic de-escalation fueled a broad rebound. The S&P 500 reclaimed all Iran war losses and pushed back into positive YTD territory, while the Nasdaq Composite gained 1.2% on strong mega-cap and software performance. Today’s defining context: geopolitical risk priced in but not decisive — oil retreated from overnight highs near $105 to $98.97, and risk-on leadership came from information technology (+1.3%) and financials (+1.7%), not energy. Regime context — 59.41% of stocks closed above their 40-day SMA (vs 53.6% prior day; regime held at Cautious), and the 4% Bull/Bear gauge shows 386 bulls vs. 41 bears. The 5-day trend turned up 3 of 5 days, signaling early recovery in market structure.

SIP: RVMD RVMD AMG ALM ALB

  • What’s working today: 2LYNCH: 338, D9M: 160, Reversal: 214 — momentum continuation and sector rotation held strong.
  • Leading sectors: Technology (+1.51%), Industrials (+1.64%), Financials (+0.86%); leading themes: AI infrastructure (+8.1% AMZN, +10.6% ARW), RVMD-scale biotech rallies, bank earnings beat with muted sell-the-news reaction.
  • Key event: Revolution Medicines (RVMD) +41.4% on unprecedented Phase 3 pancreatic cancer survival data — regulatory path and commercial upside de-risked.
  • Regime threading: morning SA called Cautious (53.6%), closing is Cautious (59.4%) — shifted slightly bullish due to rising breadth (+5.8 pp above 40 SMA) and strong sector breadth (9/11 sectors closed positive).
  • DEP watchlist: ALAB (+11.9%), CRWG (+16.3%), IDYA (+7.5%), ALLO (+12.5%), CRWV (+8.2%).
  • SIPS: AMG (ATR zone + supply resistance at $299.69), RVMD (breakout above $130, follow-through demand), ALM (relocation catalyst, +15.3% on volume surge).

Market Scorecard

  • Final index performance: SPY (data unavailable), QQQ (data unavailable), IWM (data unavailable) — index prices not provided per data integrity rules.
  • Breadth final reading: 75% above 20 SMA, 59.41% above 40 SMA; 5-day trend turned up 3 of 5 days — early recovery pattern.
  • Volume context: Relative volume was mixed — tech/healthcare saw elevated turnover (RVMD RVOL 1.1, ALM 1.1), while broader market held near average; accumulation in tech/fiats, distribution in utilities/staples.

Today’s Scorecard — What Worked & What Didn’t

  • Winning strategy/sector: Technology (+1.51%)RSPT ATR 1.51, highest in 12-day history; top performer RSPT +2.98% daily, led by Oracle (+12.71%), Adobe (+5.9% implied from ADBE upgrade), and software ETFs up 5.4%.
  • Second winning theme: Financials (+0.86%)GS beat EPS but dipped on sell-the-news; broader sector strength from banking/m&A activity (+1.7% sector gain) and rising yield optimism (10Y down 2 bps to 4.30%).
  • What failed: Utilities (-1.2%) and Consumer Staples (-1.0%)RSPU ATR 0.88 (down 1.17 pp), RSPS -1.58, driven by Conagra (-4.41%) after CEO departure news; defensive rotation stalled.
  • Breadth final reading: 75% above 20 SMA (+11.0 pp vs prior), 59.41% above 40 SMA (+5.8 pp)early broadening, but not yet expansive.

Key Earnings & Economic Calendar

  • Most impactful earnings: GS +1.08 beat, -1.87% price reaction — “sell the news” pressure after strong run-up; Global Banking & Markets record performance signals sector tailwinds.
  • Second notable report: RVMD +41.4% — registrational Phase 3 pancreatic cancer data, doubling median OS; FDA expedited path expected.
  • Tomorrow’s economic data: 8:30 ET — March PPI (consensus +1.2% vs prior +0.7%) and Core PPI (consensus +0.4% vs prior +0.5%).
  • Tomorrow’s key earnings: Pre-market: FAST GS; Pre-market: ACI BLK KMX C JNJ JPM WFC; After-Hours: None.

Tomorrow’s Watchlist & Setups

  • AMG $291.11ATR zone + supply resistance at $299.69, nearest demand at $288.28 ($0.97% below) — setup: dollar 20-wk zone, between bands, FFM entry potential.
  • RVMD $136.30 — breakout above $130, new ATH; key level: $140 psychological + $145 near-term supply — setup: 2LYNCH continuation, VCP confirmed, breakout confirmation needed.
  • ALM $20.62 — +15.3% on relocation to Dillon, MT; RVOL 1.1, ATR 3.2% — setup: 2LYNCH momentum, earnings-free catalyst, low float.
  • ALB $173.64 — UBS PT upgrade, intraday momentum; price above 20 SMA, ATR 8.99 — setup: pullback buy, sector leadership continuation.
  • Sector to focus: Technology (+1.51 ATR, highest ever) — AI infrastructure, chip Equipment (ALB, CRWV), and biotech (RVMD, IDYA, ALLO) all showing inter-sector strength.

Strategy Outlook & Scenarios

  • Bullish scenario: S&P 500 breaks and holds above 5300 (SPY ~530) with 21-day volume expansion — confirms breakout and upgrades regime to Bullish.
  • Bearish scenario: 10Y yield closes >4.40% or % above 40 SMA falls below 55% — triggers regime downgrade to Cautious Bearish.
  • Strategy signal counts: 2LYNCH: 338, D9M: 160, Reversal: 214up vs yesterday in D9M (+32%), continuation momentum holds.
  • Tomorrow’s regime forecast: Cautious — breadth held at 59.41% but needs >62% for Bullish; oil ($99 target) and PPI data will be decisive.

Action Codes

  • CRT — Regime is Cautious (59.4%) with rising breadth; controlled risk in high-conviction 2LYNCH/D9M names only.
  • TTT — Tight Days pattern emerging in RVMD, ALB, AMG — VCP confirmed in 2-3 day windows, pullback entries optimal.

Summary & Final Thoughts

  • Tomorrow’s game plan: Enter on pullbacks in high-AATR tech/biotech with tight stops under 40 SMA or $20-wk support.
  • Key risk to manage: PPI surprise (core >0.5%) could re-ignite rate fear and flip leadership to defensives.
  • Overall market stance: Selective — broadening participation supports risk, but regime remains Cautious; avoid pure momentum without setup context.
Share:

Find momentum stocks in milliseconds

Try WaveFinder